Androgen Receptor Antagonist 13 is an orally active antagonist of the androgen receptor, exhibiting an IC50 of 0.20 μM. This compound is particularly relevant in prostate cancer research, serving as a valuable tool for studying androgen signaling pathways and potential therapeutic interventions in androgen-dependent malignancies.
Androgen Receptor Antagonist 13 is an orally active antagonist of the androgen receptor, exhibiting an IC50 of 0.20 μM. This compound is particularly relevant in prostate cancer research, serving as a valuable tool for studying androgen signaling pathways and potential therapeutic interventions in androgen-dependent malignancies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: